Your browser doesn't support javascript.
loading
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.
Wang, Tongtong; Xi, Yuzhi; Raji, Annaswamy; Crutchlow, Michael; Fernandes, Gail; Engel, Samuel S; Zhang, Xiao.
  • Wang T; Epidemiology, Merck & Co., Inc., Rahway, NJ, USA.
  • Xi Y; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Raji A; Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA.
  • Crutchlow M; Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA.
  • Fernandes G; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, USA.
  • Engel SS; Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA.
  • Zhang X; Epidemiology, Merck & Co., Inc., Rahway, NJ, USA. Electronic address: xiao.zhang6@merck.com.
Ann Hepatol ; 29(1): 101154, 2024.
Article en En | MEDLINE | ID: mdl-37742743

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans / Male País como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans / Male País como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article